H. pylori-eradication therapy improves insulin sensitivity, hepatic steatosis in NAFLD
Helicobacter pylori-eradication therapy in patients with nonalcoholic fatty liver disease (NAFLD) leads to greater improvement in homeostasis model assessment-insulin resistance but exerts comparable effects on hepatic steatosis and liver enzymes as compared with diet and exercise alone, a study has shown.
H. pylori-eradication therapy improves insulin sensitivity, hepatic steatosis in NAFLD
13 Jan 2020